新闻
ICAD
--
0.00%
--
iCAD's Breast AI Platform Earns U.S. Department Of Defense Authorization To Operate; Terms Not Disclosed
 iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that the Company's breast artificial intelligence (AI) platform was
Benzinga · 3天前
iCAD’s Breast AI Platform Earns U.S. Department of Defense Authorization to Operate
Leading-edge breast cancer detection platform meets stringent U.S. government security thresholds required for use across military healthcare facilitiesNASHUA, N.H., Jan. 24, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology l...
GlobeNewswire · 3天前
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
Upgrades
Benzinga · 01/18 15:06
是时候担心了吗?分析师正在下调 iCAD, Inc.(纳斯达克股票代码:ICAD)的前景
The analysts covering iCAD, Inc. ( NASDAQ:ICAD ) delivered a dose of negativity to shareholders today, by making a...
Simply Wall St. · 01/12 15:25
BRIEF-ICAD Appoints New Members To Its Board Of Directors
reuters.com · 01/11 14:39
Mid-Afternoon Market Update: Dow Jumps 250 Points; Avrobio Shares Slide
Toward the end of trading Tuesday, the Dow traded up 0.70% to 36,839.62 while the NASDAQ fell 1.57% to 15,583.77. The S&P also fell, dropping 0.03% to 4,794.93.
Benzinga · 01/04 19:40
Mid-Day Market Update: Nasdaq Dips 250 Points; TherapeuticsMD Shares Surge
Midway through trading Tuesday, the Dow traded up 0.66% to 36,827.65 while the NASDAQ fell 1.63% to 15,574.50. The S&P also fell, dropping 0.08% to 4,792.93.
Benzinga · 01/04 17:17
Stocks That Breached 52-Week Lows Today
Stocks That Managed to Breach 52-Week Lows Tuesday Morning Before 10 am Tuesday, 44 stocks made new 52-week lows. 52-Week High And Low Highlights: Block (NYSE: SQ) was the biggest company on a market cap basis to set aStocks That Managed to Breach 52-Week ...
Benzinga · 01/04 15:58
Plus Therapeutics、NLS Pharmaceutics 是医疗保健行业的佼佼者; AVROBIO 和 Genprex 处于亏损状态
Gainers: Plus Therapeutics PSTV +67%; NLS Pharmaceutics NLSP +31%. NeuroBo Pharmaceuticals (NASDAQ:NRBO) +29%. Immix Biopharma IMMX +23%. iSpecimen Inc. (NASDAQ:ISPC) +15%. Losers: AVROBIO (NASDAQ:AVRO) -32%; Genprex (NASDAQ:GNPX) -20%. Valneva SE American...
Seekingalpha · 01/04 15:03
iCAD 将参加第 11 届 LifeSci Partners 虚拟企业访问活动
Company’s President and incoming CEO to participate in a panel discussion titled “Med Tech / Digital Tools: What's the Mindset for 2022?” on January 5, 2022 at 2:00 pm ETNASHUA, N.H., Dec. 23, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global me...
GlobeNewswire · 2021/12/23 13:00
iCAD Granted U.S. Patent #11,205,265 'System and method for assessing breast cancer risk using imagery'
View patent here
Benzinga · 2021/12/21 11:05
iCAD Reports First Patient With Recurrent Glioblastoma Was Treated With Co.'s Xoft Axxent Electronic Brachytherapy System
Treatment marks initiation of international multicenter trial evaluating targeted radiation therapy and bevacizumab for the treatment of the most common and aggressive type of malignant brain tumor Intriguing research
Benzinga · 2021/12/14 13:12
iCAD, Inc.(纳斯达克股票代码:ICAD)的执行主席兼首席执行官 Michael Klein 刚刚购买了 51% 以上的股份
Whilst it may not be a huge deal, we thought it was good to see that the iCAD, Inc. ( NASDAQ:ICAD ) Executive Chairman...
Simply Wall St. · 2021/12/12 11:53
iCAD to Participate at the Imagine AI + Healthcare Investor Summit
NASHUA, N.H., Dec. 06, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, President and incoming Chief Executive Officer, ...
GlobeNewswire · 2021/12/06 18:39
iCAD appoints Stacey Stevens as president, CEO
iCAD (ICAD -9.6%) has appointed Stacey Stevens as iCAD's President and Chief Executive Officer, effective March 1, 2022. Stevens, who has served as the company's President since 2019, will also
Seekingalpha · 2021/12/06 15:00
BRIEF-iCAD Inc Appoints Stacey Stevens As Co's President And Chief Executive Officer
reuters.com · 2021/12/06 14:12
iCAD Announces Compelling New and Real-World Data Demonstrating the Value of ProFound AI to be Presented at RSNA 2021
World’s first FDA cleared AI breast cancer detection software to be highlighted in three scientific presentations at largest radiological meeting in the world iCAD’s innovative breast health solutions, including ProFound AI Risk and PowerLook Density Asses...
GlobeNewswire · 2021/11/29 13:00
Granahan Investment Management Inc Buys Array Technologies Inc, ThredUp Inc, Riskified, Sells , ...
GuruFocus News · 2021/11/15 17:38
iCAD to Host 2nd Annual Virtual Investor Webinar on Company’s Innovative Solutions for Cancer Detection and Treatment
Leading clinical and administrative experts to discuss how leveraging iCAD’s Breast Health Solutions and the Xoft System can enhance clinical efficiency and improve outcomes for patients Webinar taking place on Thursday, November 18 from 3:00 to 4:30 PM ET...
GlobeNewswire · 2021/11/11 13:00
Insider Sell: Icad
MT Newswires · 2021/11/10 17:38
微牛提供丰富的实时ICAD股票新闻,让你可以通过多个平台了解ICAD股票行情最新动态,这些免费的ICAD US新闻可以帮助你做出明智投资。
ICAD 简况
ICAD Inc是一家提供癌症检测和治疗解决方案的全球医疗技术公司。该公司通过两个部门运营:癌症检测(检测)部门和癌症治疗(治疗)部门。检测部门包括其图像分析和工作流程产品、各种人工智能(AI)、计算机辅助检测(CAD)系统以及二维(2D)和三维(3D)乳房X线摄影、磁共振成像(MRI)和计算机断层扫描(CT)的工作流程解决方案。治疗部门由其放射治疗产品组成,并提供无同位素癌症治疗平台技术Xoft System。该公司通过其直销机构以及各种原始设备制造商合作伙伴、分销商和经销商销售其产品。